GoodRx Holdings (GDRX) Operating Expenses (2019 - 2026)

GoodRx Holdings' Operating Expenses history runs 8 years deep, the most recent figure standing at $180.0 million for Q1 2026.

• In Q1 2026, Operating Expenses changed 0.23% year-over-year to $180.0 million; the TTM figure through Mar 2026 stood at $709.8 million (down 0.81% YoY), while the FY2025 annual figure was $709.4 million, down 2.36% from the prior year.
• Operating Expenses came in at $180.0 million for Q1 2026 at GoodRx Holdings, up from $172.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $218.3 million in Q3 2023 to a low of $171.4 million in Q2 2023.
• A 5-year average of $185.8 million and a median of $180.7 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses grew 17.85% in 2023 and declined 19.9% in 2024, its largest moves.
• GoodRx Holdings' Operating Expenses stood at $182.4 million in 2022, then advanced by 17.85% to $214.9 million in 2023, then slipped by 16.07% to $180.4 million in 2024, then declined by 4.6% to $172.1 million in 2025, then increased by 4.59% to $180.0 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $180.0 million, $172.1 million, and $181.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison